desoxycorticosterone acetate has been researched along with Cardiac Failure in 12 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Calcitriol treatment attenuated FGF23-induced cardiac fibrosis and improved diastolic function via inhibition of transforming growth factor-β signaling." | 1.91 | Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension. ( Honda, H; Kato, T; Koiwa, F; Mizobuchi, M; Ogata, H; Saito, T, 2023) |
| "Metformin-treated mice have unaltered PEVK phosphorylation but increased phosphorylation of PKA sites in the N2B element, a change which has previously been shown to lower titin's stiffness." | 1.51 | Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance. ( Gotthardt, M; Granzier, HL; Liss, M; Methawasin, M; Slater, RE; Strom, JG; Sweitzer, N, 2019) |
| "Obesity and hypertension are prevalent comorbidities in heart failure with preserved ejection fraction." | 1.51 | Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction. ( Brandt, MM; Cheng, C; Cramer, MJ; Duncker, DJ; Joles, JA; Krebber, MM; Mokry, M; Nguyen, ITN; van de Wouw, J; Verhaar, MC, 2019) |
| "We induced hypertension and hyperlipidemia in landrace pigs (n = 8) by deoxycorticosteroneacetate (DOCA, 100 mg/kg, 90-day-release subcutaneous depot) and a Western diet (WD) containing high amounts of salt, fat, cholesterol, and sugar for 12 wk." | 1.42 | A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. ( Alogna, A; Casadei, B; Eller, K; Eller, P; Hamdani, N; Höfler, G; Kirsch, A; Linke, WA; Maechler, H; Manninger, M; Pieske, BM; Post, H; Reilly, S; Schauer, S; Schwarzl, M; Seiler, S; Steendijk, P; Verderber, J; Zirngast, B; Zweiker, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, J | 1 |
| Chang, L | 1 |
| Wang, D | 1 |
| Ji, C | 1 |
| Zhang, S | 1 |
| Hou, Y | 1 |
| Wu, Y | 1 |
| Wu, H | 2 |
| Tang, LX | 2 |
| Wang, XM | 2 |
| Li, LP | 2 |
| Chen, XK | 2 |
| He, YJ | 2 |
| Yang, DZ | 2 |
| Shi, Y | 2 |
| Shou, JL | 2 |
| Zhang, ZS | 2 |
| Wang, L | 2 |
| Lu, BJ | 2 |
| An, SM | 2 |
| Zeng, CY | 2 |
| Wang, WE | 2 |
| Saito, T | 1 |
| Mizobuchi, M | 1 |
| Kato, T | 1 |
| Ogata, H | 1 |
| Koiwa, F | 1 |
| Honda, H | 1 |
| Samuelsson, AM | 1 |
| Bartolomaeus, TUP | 1 |
| Anandakumar, H | 1 |
| Thowsen, I | 1 |
| Nikpey, E | 1 |
| Han, J | 1 |
| Marko, L | 1 |
| Finne, K | 1 |
| Tenstad, O | 1 |
| Eckstein, J | 1 |
| Berndt, N | 1 |
| Kühne, T | 1 |
| Kedziora, S | 1 |
| Sultan, I | 1 |
| Skogstrand, T | 1 |
| Karlsen, TV | 1 |
| Nurmi, H | 1 |
| Forslund, SK | 1 |
| Bollano, E | 1 |
| Alitalo, K | 1 |
| Muller, DN | 1 |
| Wiig, H | 1 |
| Smart, CD | 1 |
| Fehrenbach, DJ | 1 |
| Wassenaar, JW | 1 |
| Agrawal, V | 1 |
| Fortune, NL | 1 |
| Dixon, DD | 1 |
| Cottam, MA | 1 |
| Hasty, AH | 1 |
| Hemnes, AR | 1 |
| Doran, AC | 1 |
| Gupta, DK | 1 |
| Madhur, MS | 1 |
| Hao, JM | 1 |
| Sun, P | 1 |
| Zeng, Y | 1 |
| Zhang, H | 1 |
| Zhang, ZD | 1 |
| Chang, LP | 1 |
| Hou, YL | 1 |
| Slater, RE | 1 |
| Strom, JG | 1 |
| Methawasin, M | 1 |
| Liss, M | 1 |
| Gotthardt, M | 1 |
| Sweitzer, N | 1 |
| Granzier, HL | 1 |
| Brandt, MM | 1 |
| Nguyen, ITN | 1 |
| Krebber, MM | 1 |
| van de Wouw, J | 1 |
| Mokry, M | 1 |
| Cramer, MJ | 1 |
| Duncker, DJ | 1 |
| Verhaar, MC | 1 |
| Joles, JA | 1 |
| Cheng, C | 1 |
| Schwarzl, M | 1 |
| Hamdani, N | 1 |
| Seiler, S | 1 |
| Alogna, A | 1 |
| Manninger, M | 1 |
| Reilly, S | 1 |
| Zirngast, B | 1 |
| Kirsch, A | 1 |
| Steendijk, P | 1 |
| Verderber, J | 1 |
| Zweiker, D | 1 |
| Eller, P | 1 |
| Höfler, G | 1 |
| Schauer, S | 1 |
| Eller, K | 1 |
| Maechler, H | 1 |
| Pieske, BM | 1 |
| Linke, WA | 1 |
| Casadei, B | 1 |
| Post, H | 1 |
| DAVIS, JO | 1 |
| HOWELL, DS | 1 |
| SOUTHWORTH, JL | 1 |
| SCHWEITZER, P | 1 |
| NEUBAUER, E | 1 |
| STANCAK, A | 1 |
| PRINO, G | 1 |
12 other studies available for desoxycorticosterone acetate and Cardiac Failure
| Article | Year |
|---|---|
Periplocin Alleviates Cardiac Remodeling in DOCA-Salt-Induced Heart Failure Rats.
Topics: Animals; Desoxycorticosterone Acetate; Heart Failure; Myocytes, Cardiac; Rats; Stroke Volume; Ventri | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension.
Topics: Animals; Blood Pressure; Calcitriol; Desoxycorticosterone Acetate; Fibroblast Growth Factor-23; Fibr | 2023 |
VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Heart Failure; Heart Failure, Systolic; Hyperte | 2023 |
Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure.
Topics: Animals; Cardiomyopathies; Desoxycorticosterone Acetate; Heart Failure; Humans; Hypertension; Leukoc | 2023 |
Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
Topics: Animals; Cytokines; Desoxycorticosterone Acetate; Heart Failure; Interleukin-10; Matrix Metalloprote | 2023 |
Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.
Topics: Animals; Desoxycorticosterone Acetate; Diastole; Disease Models, Animal; Heart Failure; Heart Ventri | 2019 |
Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Topics: Animals; Apoptosis; Capillaries; Desoxycorticosterone Acetate; Disease Progression; Fatty Acids; Fib | 2019 |
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Topics: Animals; Cardiomyopathies; Connectin; Desoxycorticosterone Acetate; Diet, Western; Dilatation, Patho | 2015 |
Mechanisms of fluid and electrolyte retention in experimental preparations in dogs. III. Effect of adrenalectomy and subsequent desoxycorticosterone acetate administration on ascites formation.
Topics: Adrenal Cortex; Adrenalectomy; Animals; Ascites; Desoxycorticosterone; Desoxycorticosterone Acetate; | 1953 |
[THE EFFECT OF DOCA ON MUSCLE METABOLISM IN CARDIAC DECOMPENSATION].
Topics: Carbon Dioxide; Desoxycorticosterone; Desoxycorticosterone Acetate; Glucose; Heart Failure; Metaboli | 1963 |
[Reaction of chlorothiazide in fluid retention induced by pitressin and desoxycorticosterone acetate in rats].
Topics: Animals; Chlorothiazide; Desoxycorticosterone; Desoxycorticosterone Acetate; Heart Failure; Rats; Va | 1959 |